Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
Plans for new incubators were announced in two different cities. Guardant is funding a series of trials around the country in people whose genetic or lifestyle profiles put them at high risk of five types of cancer. We’ve got those stories, plus a spate of financings and deals, a legal feud, and other news below.
67 
Let's personalize your content